{
    "nct_id": "NCT05673018",
    "official_title": "REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity",
    "inclusion_criteria": "For Galleri + UC (Galleri-Tested Arm):\n\nParticipants are eligible to be included in the study only if all of the following criteria apply:\n\n* Aged ≥50 years with Medicare coverage,\n* Eligible to receive the Galleri test, based on a determination by the study investigator or designee that the test is clinically appropriate,\n* Capable of giving informed consent that is legally effective (consent provided by a legally authorized representative is not permitted in this protocol), and\n* Able to comprehend and respond to questions in participant questionnaires. Comprehension level is determined by the study investigator or designee.\n\nFor UC (Not Galleri-tested Arm):\n\n* Aged ≥ 50 years with Medicare coverage,\n* Have had ≥ 1 UC visit\nHealthy volunteers allowed\nMust have minimum age of 50 Years",
    "exclusion_criteria": "For Galleri + UC (Galleri-Tested Arm):\n\n* Having had a previous Galleri test not associated with this study.\n* Undergoing clinical evaluation for symptoms suspicious for cancer.\n* Personal history of invasive solid tumor or hematologic malignancy, diagnosed within the 3 years prior to expected enrollment date, or diagnosed greater than 3 years prior to expected enrollment date and never treated.\n* Individuals with a diagnosis of non-metastatic basal cell carcinoma and squamous cell carcinoma of the skin are not excluded.\n* Prior/Concurrent Concomitant Therapy (Medications/Treatments):\n* Definitive treatment for invasive solid tumor or hematologic malignancy within the 3 years prior to expected enrollment date.\n* Adjuvant hormone therapy for cancer (i.e., for breast or prostate cancer) is not an exclusion criterion.\n* Current pregnancy\n* Individuals who will not be able to comply with the protocol procedures.\n* Individuals who are not currently registered patients at a participating center.\n* Previous or current employees or contractors of GRAIL.\n\nFor UC (Not Galleri-tested Arm):\n\n* Undergoing or referred for diagnostic evaluation due to clinical suspicion for cancer (e.g., referred to a medical or surgical oncologist, or scheduled for biopsy on the basis of a suspicious imaging abnormality).\n* Personal history of invasive solid tumor or hematologic malignancy, diagnosed within the 3 years prior to expected enrollment date, or diagnosed greater than 3 years prior to expected enrollment date and never treated.\n* Individuals with a diagnosis of non-metastatic basal cell carcinoma and squamous cell carcinoma of the skin are not excluded.\n* Prior/Concurrent Concomitant Therapy (Medications/Treatments):\n* Definitive treatment for invasive solid tumor or hematologic malignancy within the 3 years prior to expected enrollment date.\n* Adjuvant hormone therapy for cancer (e.g. for breast or prostate cancer) is not an exclusion criterion.\n* Current pregnancy.",
    "miscellaneous_criteria": ""
}